33 reports

  • Asthma
  • Hiatal hernia
  • Gastrointestinal Drug
  • AstraZeneca PLC
  • Eisai Co., Ltd.
  • Johnson & Johnson
  • Takeda Pharmaceutical Company Limited

Other co-morbidities associated with GERD are asthma, gall bladder disease, otitis, sinusitis, anxiety and depression (Hungin et al., 2005).

  • Gastrointestinal Drug
  • World
  • Market Size
  • AstraZeneca PLC
  • Takeda Pharmaceutical Company Limited
  • 4.1 BIBLIOGRAPHY

Annals of Allergy, Asthma and Immunology; ##(##): ##-##.

  • Digestive System Disorder
  • Gastrointestinal Drug
  • OTC
  • Italy
  • Forecast

NTPC possesses more than ## products, the main products including Zhudan (Ondansetron Hydrochloride), Zhuxing (Granisetron Hydrochloride), and Zhurui (Tamoxifen Citrate), involving in anticancer, anticancer assistant drugs, hypertension, antilipid, antipyretic, analgesia, anti asthma and

  • Gastrointestinal Drug
  • China
  • Demand
  • Market Size
  • Xian-Janssen Pharmaceutical Ltd.

asthma), Xieke® Valsartan capsule (Antihypertensive), Danke® Risperidone tablet(anti-schizophrenic), Hengke® Glipizide controlled-release tablet (anti-diabetic), Jinyike® ##-peptide Somatostatin, Fentaike® Fentanyl patch (pain-release), Jiabeike® Gabexate (treatment of pancreatitis), etc.

  • Gastrointestinal Drug
  • China
  • Demand
  • AstraZeneca China Inc.
  • Eisai Co., Ltd.

The company mainly sells drugs treating HBV, asthmas and infections.

  • Gastrointestinal Drug
  • China
  • Supply
  • Shandong Xinhua Pharmaceutical Company Limited
  • Tianjin Pharmaceutical Co., Ltd.

NTPC possesses more than ## products, the main products including Zhudan (Ondansetron Hydrochloride), Zhuxing (Granisetron Hydrochloride), and Zhurui (Tamoxifen Citrate), involving in anticancer, anticancer assistant drugs, hypertension, antilipid, antipyretic, analgesia, anti asthma and

  • Gastrointestinal Drug
  • China
  • AstraZeneca PLC
  • Nanjing Aosaikang Medicinal Group
  • Xian-Janssen Pharmaceutical Ltd.

The treatment aims to eliminate the symptoms such as heartburn, acidic taste in mouth, hoarseness, dry cough, asthma etc & cure the disease.

  • Gastrointestinal Drug
  • OTC
  • Pharmaceutical
  • World
  • Forecast

Asthma og Allergiforbundet Norwegian Association of Pharmaceutical Manufacturers Norwegian Pharmacy Association Opplysningskontor for Frukt & Grønt Optikerforbundet The Association of the Pharmaceutical Industry in Norway Adresseavisen Advertising Flyers Aftenposten bizkit. no Dagens Me

  • Gastrointestinal Drug
  • OTC
  • Norway
  • Demand

asthma), Xieke® Valsartan capsule (Antihypertensive), Danke® Risperidone tablet(anti-schizophrenic), Hengke® Glipizide controlled-release tablet (anti-diabetic), Jinyike® ##-peptide Somatostatin, Fentaike® Fentanyl patch (pain-release), Jiabeike® Gabexate (treatment of pancreatitis), etc.

  • Gastrointestinal Drug
  • China
  • AstraZeneca China Inc.
  • Eisai Co., Ltd.
  • Nanjing Aosaikang Medicinal Group
  • 5.7.2. PRODUCT PORTFOLIO

IT HAS THE POTENTIAL TO CONTROL INFLAMMATION IN PATIENTS SUFFERING FROM EOSINOPHILIC ASTHMA.

  • Gastrointestinal Drug
  • Pharmaceutical
  • United States
  • Market Size
  • MicroBiome Therapeutics LLC

Also, in October 2013, iSonea (a medical technology company) signed an agreement with TREMOR (a division of P& G) to promote iSonea' s products for asthma in women. ##. ##. ## Recent developments Company details Description Key highlights Key partnerships March ##, 2015: Announces a $##

  • Gastrointestinal Drug
  • World
  • GlaxoSmithKline plc
  • Perrigo Company
  • Pfizer Inc.

A large number of people suffer from respiratory problems such as hay fever and asthma, and the poor air quality worsens their health PROSPECTS Passport ## conditions.

  • Gastrointestinal Drug
  • OTC
  • Vitamin
  • China
  • Demand
  • REFLUX ESOPHAGITIS (GASTROESOPHAGEAL REFLUX DISEASE) THERAPEUTICS CLINICAL TRIALS MARKET, GLOBAL, CLINICAL TRIALS BY
  • JANSSEN GLOBAL SERVICES, LLC, 2015*

A large number of children under ## years with reflux esophagitis may experience dry cough, asthma symptoms, or trouble swallowing.

  • Gastrointestinal Drug
  • World
  • AstraZeneca PLC
  • Pfizer Inc.
  • Takeda Pharmaceutical Company Limited

The company mainly sells drugs treating HBV, asthmas and infections.

  • Gastrointestinal Drug
  • China
  • Supply
  • Shandong Xinhua Pharmaceutical Company Limited
  • Tianjin Pharmaceutical Co., Ltd.

asthma, and non-opioid-induced paralytic ileus.

  • Gastrointestinal Drug
  • Europe
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Progenics Pharmaceuticals, Inc.
  • CLINICAL TRIAL OVERVIEW OF TOP COMPANIES
  • ESOPHAGEAL DISEASES THERAPEUTICS CLINICAL TRIALS MARKET, GLOBAL, CLINICAL TRIALS BY TAKEDA PHARMACEUTICAL COMPANY

Asthma Control of Rabeprazole Given Twice Daily in Subjects with Asthma Phase III Completed Improvement in Bronchial Asthma in Patients With Extraesophageal Reflux After Acid Suppression Phase II Completed Influence of Hygiene-dietetic Habits and Treatment Adherence on the

  • Gastrointestinal Drug
  • World
  • AstraZeneca PLC
  • Pfizer Inc.
  • Takeda Pharmaceutical Company Limited
  • CLINICAL TRIAL OVERVIEW OF TOP COMPANIES
  • ESOPHAGITIS THERAPEUTICS CLINICAL TRIALS MARKET, GLOBAL, CLINICAL TRIALS BY TAKEDA PHARMACEUTICAL COMPANY LIMITED,

Asthma Control of Rabeprazole Given Twice Daily in Subjects with Asthma Phase III Completed Improvement in Bronchial Asthma in Patients With Extraesophageal Reflux After Acid Suppression Phase II Completed Influence of Hygiene-dietetic Habits and Treatment Adherence on the

  • Gastrointestinal Drug
  • World
  • AstraZeneca PLC
  • Pfizer Inc.
  • Takeda Pharmaceutical Company Limited

The panel expressed concerns over side-effects and the possibility for off-label use for use in asthma patients.

  • Gastrointestinal Drug
  • United States
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Pfizer Inc.

Asthma Urinary tract infection Renal cyst Oesophagitis Hiatus hernia Duodenitis Gastroenteritis ##/ ##(##. ##%) ##/ ## (##. ##%) ##/ ## (##. ##%) Cholecystitis chronic ##/ ## (##. ##%) ##/ ## (##. ##%) ##/ ## (##. ##%) ##/ ## (##. ##%) Based on the study results published, Glo

  • Drug Discovery And Development
  • Gastrointestinal Drug
  • United States
  • World
  • Salix Pharmaceuticals, Ltd.

Patent and Trademark Office for a pending patent application, which covers the use of MN-## for the treatment of acute exacerbations of asthma.

  • Digestive System Disorder
  • Gastrointestinal Drug
  • Pharmaceutical
  • United States
  • Product Initiative

Patent and Trademark Office for a pending patent application, which covers the use of MN-## for the treatment of acute exacerbations of asthma.

  • Gastrointestinal Drug
  • Therapy
  • United States
  • Product Initiative
  • Ironwood Pharmaceuticals, Inc.
  • Clinical Trial profile. 895 Trial Title
  • Target

Asthma Anti-Interleukin-## (IL##) Monoclonal Antibody (MAb) in Prednisone-dependent Eosinophilic Asthma GDCT## NCT##, RES-## Gastrointestinal Asthma, Eosinophilic Esophagitis (CD##, Hematopoietic Progenitor Cell Antigen CD## (CD##), T Cell Surface Glycoprotein C

  • Clinical Trial
  • Digestive System Disorder
  • Gastrointestinal Drug
  • Pharmaceutical
  • World

It offers products and vaccines that are used in the treatment of chronic kidney disease, Parkinson' s disease, asthma, hemophilia, obesity, chronic obstructive pulmonary disease (COPD) and chemotherapy-induced nausea and vomiting, among others.

  • Gastrointestinal Drug
  • United States
  • World
  • Product Initiative
  • Ardelyx, Inc.
  • Official Title
  • 5. ALL THE TRIALS INCLUDED ARE UNIQUE TRIALS.

Asthma Anti-Interleukin-## (IL##) Monoclonal Antibody (MAb) in Prednisone-dependent Eosinophilic Asthma GDCT## NCT##, RES-## Gastrointestinal Asthma, Eosinophilic Esophagitis (CD##, Hematopoietic Progenitor Cell Antigen CD## (CD##), T Cell Surface Glycoprotein C

  • Clinical Trial
  • Digestive System Disorder
  • Gastrointestinal Drug
  • Pharmaceutical
  • World

The company' s products include penthrox, asthma and COPD, medical devices and veterinary products.

  • Gastrointestinal Drug
  • Healthcare
  • Pharmaceutical
  • United States
  • Purdue Pharma L.P.

The company' s proprietary platform technology is applied in various therapeutic areas such as cancer, pain, asthma, inflammation, sepsis and others.

  • Blood Disease
  • Gastrointestinal Drug
  • United States
  • Product Initiative
  • Pfizer Inc.

Its target treatment areas comprise endobronchial cancer, esophageal cancer, high grade dysplasia in Barrett' s esophagus, asthma and head lice infestation among others.

  • Biopharmaceutical
  • Digestive System Disorder
  • Gastrointestinal Drug
  • United States
  • RedHill Biopharma Ltd.

Aslan' s ASLAN## is a small molecule inhibitor of dihydroorotate dehydrogenase inhibitor to treat tumors; and ASLAN## is a full human monoclonal antibody that reduces exacerbation in moderate or severe asthma and improves the functioning of lungs.

  • Digestive System Disorder
  • Gastrointestinal Drug
  • Therapy
  • United States
  • Product Initiative
  • 5. All the trials included are unique trials.

Asthma, Chronic Cough, Emesis (Vomiting), Reflux Esophagitis (Gastroesophageal Reflux Disease) Completed Phase II Interventional Gastrotuss baby syrup; lansoprazole Federico II University ## Feb 2013 ## Dec 2013 ## ## ## ## ## Clinical Trial profile. ## Trial Title Official Title Trial Ident

  • Digestive System Disorder
  • Gastrointestinal Drug
  • Pharmaceutical
  • World
  • Product Initiative